Health service utilization among Alzheimer's disease patients: Evidence from managed care

Alzheimer's and Dementia

Volumn 4, Issue 5, 2008, Pages 361-367

  Frytak, Jennifer R ^a   Henk, Henry J ^a   Zhao, Yang ^b   Bowman, Lee ^b   Flynn, Jennifer A ^b   Nelson, Michael ^a  

^a i3 Innovus   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Alzheimer's disease; Cost; Health service utilization; Managed care claims data

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; NOOTROPIC AGENT; RIVASTIGMINE; TACRINE;

ACCIDENTAL INJURY; AGE; AGED; ALCOHOL ABUSE; ALZHEIMER DISEASE; ANXIETY DISORDER; ARTHRITIS; ARTICLE; ATHEROSCLEROSIS; BIPOLAR DISORDER; COHORT ANALYSIS; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; DRUG ABUSE; FALLING; FEMALE; FRACTURE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MANAGED CARE; MEDICAL RESEARCH; MEDICARE; OUTCOME ASSESSMENT; PARKINSON DISEASE; PATIENT CARE; PRIORITY JOURNAL; PSYCHOSIS; RESPIRATORY TRACT DISEASE; RISK ASSESSMENT; SEX DIFFERENCE; STROKE; UNITED STATES;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COST OF ILLNESS; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MANAGED CARE PROGRAMS; RISK FACTORS; UNITED STATES;

EID: 51349092500     PISSN: 15525260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jalz.2008.02.007     Document Type: Article

References (22)

1. Hebert L.E., Scherr P.A., Bienias J.L., Bennett D.A., and Evans D.A. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol 60 (2003) 1119-1122
2. Ernst R.L., and Hay J.W. The US economic and social costs of Alzheimer's disease revisited. Am J Public Health 84 (1994) 1261-1264
3. Ernst R.L., Hay J.W., Fenn C., Tinklenberg J., and Yesavage J.A. Cognitive function and the costs of Alzheimer's disease: an exploratory study. Arch Neurol 54 (1997) 687-693
4. Cummings J.L. Alzheimer's disease. N Engl J Med 351 (2004) 56-67
5. Koppel R. Alzheimer's disease. the costs to U.S. businesses in 2002. Wyncote, PA: Social Research Corporation. Prepared for the Alzheimer's Association, 2002.
6. Hill J.W., Futterman R., Duttagupta S., Mastey V., Lloyd J.R., and Fillit H. Alzheimer's disease and related dementias increase costs of comorbidities in managed Medicare. Neurology 58 (2002) 62-70
7. Leon J., Cheng C.K., and Neumann P.J. Alzheimer's disease care: costs and potential savings. Health Aff 17 (1998) 206-216
8. Max W, Webber P, Fox P. Alzheimer's disease. the unpaid burden of caring. J Aging Health 1995;7179-99.
9. Brummel-Smith K., Weiner M., Powe N.R., Weller W.E., Shaffer T.J., and Anderson G.F. Alzheimer's disease under managed care: implications from Medicare utilization and expenditure patterns. J Am Geriatr Soc 46 (1998) 762-770
10. Menzin J., Lang K., Friedman M., Neumann P., and Cummings J.L. The economic cost of Alzheimer's disease and related dementias to the California Medicaid Program ("Medi-Cal") in 1995. Am J Geriatr Psychiatry 7 (1999) 300-308
11. Gutterman E.M., Markowitz J.S., Lewis B., and Fillit H. Cost of Alzheimer's disease and related dementia in managed-Medicare. J Am Geriatr Soc 47 (1999) 1065-1071
12. Richards K.M., Shepherd M.D., Crismon M.L., Snyder E.H., and Jermain D.M. Medical services utilization and charge comparisons between elderly patients with and without Alzheimer's disease in a managed care organization. Clin Ther 22 (2000) 775-791
13. Martin B.C., Ricci J.F., Kotzan J.A., Lang K., and Menzen J. The net cost of Alzheimer's disease and related dementia: a population-based study of Georgia Medicaid recipients. Alzheimer Dis Assoc Disord 14 (2000) 151-159
14. Sloan F.A., and Taylor Jr. D.H. Effect of Alzheimer's disease on the cost of treating other diseases. Alzheimer Dis Assoc Disord 16 (2002) 137-143
15. Fillit H., Hill J.W., and Futterman R. Health care utilization and costs of Alzheimer's disease: the role of comorbid conditions, disease stage, and pharmacotherapy. Fam Med 34 (2002) 528-535
16. McCormack L.A., Gabel J.R., and Whitmore H. Trends in retiree health benefits. Health Aff 21 (2002) 169-176
17. Newcomer R., Clay T., Luxenberg J.S., and Miller R.H. Misclassification and selection bias when identifying Alzheimer's disease solely from Medicare claims records. J Am Geriatr Soc 47 (1999) 215-219
18. Leibson C., Owens T., O'Brien P., Waring S., Tangalos E., Hanson V., et al. Use of physician and acute care services by persons with and without Alzheimer's disease: a population-based comparison. J Am Geriatr Soc 47 (1999) 864-869
19. Blough D.K., Madden C.W., and Hornbrook M.C. Modeling risk using generalized linear models. J Health Econ 18 (1999) 153-171
20. Manning W.G. The logged dependent variable, heteroscedasticity, and the retransformation problem. J Health Econ 17 (1998) 283-295
21. Efron B., and Tibshirani R. An introduction to the bootstrap (1993), Chapman & Hall, New York
22. Manning W.G., Fryback D.G., and Weinstein M.C. Reflecting uncertainty in cost-effectiveness analysis. In: Gold M.R., Siegel J.E., Russell L.B., and Weinstein M.C. (Eds). Cost-effectiveness in health and medicine (1996), Oxford University Press, New York 247-275